Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Dec 15;90(24):11830-4.
doi: 10.1073/pnas.90.24.11830.

Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase

S E Braun  1 , E L Aronovich, R A Anderson, P L Crotty, R S McIvor, C B Whitley
Affiliations

Metabolic correction and cross-correction of mucopolysaccharidosis type II (Hunter syndrome) by retroviral-mediated gene transfer and expression of human iduronate-2-sulfatase

S E Braun et al. Proc Natl Acad Sci U S A. .

Abstract

To explore the possibility of using gene transfer to provide iduronate-2-sulfatase (IDS; EC 3.1.6.13) enzyme activity for treatment of Hunter syndrome, an amphotropic retroviral vector, L2SN, containing the human IDS coding sequence was constructed and studied for gene expression in vitro. Lymphoblastoid cell lines (LCLs) from patients with Hunter syndrome were transduced with L2SN and expressed high levels of IDS enzyme activity, 10- to 70-fold higher than normal human peripheral blood leukocytes or LCLs. Such L2SN-transduced LCLs failed to show accumulation of 35SO4 into glycosaminoglycan (35SO4-GAG), indicating that recombinant IDS enzyme participated in GAG metabolism. Coculture of L2SN-transduced LCLs with fibroblasts from patients with Hunter syndrome reduced the accumulation of 35SO4-GAG. These results demonstrated retroviral-mediated IDS gene transfer into lymphoid cells and the ability of such cells to provide recombinant enzyme for intercellular metabolic cross-correction.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1971 Feb;68(2):303-7 - PubMed
    1. Birth Defects Orig Artic Ser. 1986;22(1):135-52 - PubMed
    1. Virology. 1973 Apr;52(2):456-67 - PubMed
    1. Anal Biochem. 1976 May 7;72:248-54 - PubMed
    1. Birth Defects Orig Artic Ser. 1986;22(1):31-9 - PubMed

Publication types

MeSH terms